<DOC>
	<DOC>NCT00817986</DOC>
	<brief_summary>The purpose of the study is to evaluate safety and tolerability of arbaclofen placarbil sustained release tablets taken every 12 hours compared to placebo in subjects with acute back spasms in the lumbar region.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back Spasms</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Arbaclofen placarbil</mesh_term>
	<mesh_term>Baclofen</mesh_term>
	<criteria>1. Acute moderate to severe muscle spasms in the lumbar region, as indicated by a minimum Visual Analog Scale pain severity score of 4.0 cm, beginning either: within four days prior to screening for subjects who do not require a 24hour washout Or within three days for subjects who require a 24hour washout 2. Willing to discontinue all analgesics (e.g. NSAIDS, COX2 inhibitors, acetaminophen), aspirin &gt;81 mg/day, shortacting muscle relaxants (i.e. carisoprodol, Soma®), and herbal remedies for pain at least 24 hours prior to first dose and to refrain from use during the study (cardioprotective doses of aspirin ≤ 81 mg /day are allowed). 1. Clinically significant abnormal neurological history or examination at screening (excluding back spasm), including lumbar radicular symptoms, spinal stenosis, foot drop, herniated nucleus pulposus, or other structural defects 2. Subjects with back spasm related to major trauma to the region 3. Subjects with muscle spasms due to a workrelated injury or subjects involved in any injuryrelated litigation 4. Subjects using any of the following medications at screening: Opioids, both short and longacting including but not limited to: morphine, fentanyl patch, oxycodone, tramadol) benzodiazepines, such as valium and lorazepam cyclobenzaprine containing drugs (e.g., Flexeril, Amrix) carisoprodol (e.g., Soma®) within 24 hours of screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Acute back pain in the lumbar region</keyword>
</DOC>